ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $671,608 | -3.0% | 187,600 | 0.0% | 0.00% | – |
Q2 2023 | $692,244 | +88.1% | 187,600 | +68.7% | 0.00% | – |
Q1 2023 | $368,072 | -14.7% | 111,200 | 0.0% | 0.00% | – |
Q4 2022 | $431,456 | +285.2% | 111,200 | +141.7% | 0.00% | – |
Q3 2022 | $112,000 | +124.0% | 46,000 | +82.5% | 0.00% | – |
Q2 2022 | $50,000 | -65.3% | 25,200 | -69.3% | 0.00% | – |
Q1 2021 | $144,000 | -10.6% | 82,000 | -0.8% | 0.00% | – |
Q4 2020 | $161,000 | -37.8% | 82,700 | -23.8% | 0.00% | – |
Q3 2020 | $259,000 | -52.2% | 108,500 | -41.3% | 0.00% | – |
Q2 2020 | $542,000 | +107.7% | 184,900 | +104.3% | 0.00% | – |
Q1 2020 | $261,000 | +177.7% | 90,500 | +283.5% | 0.00% | – |
Q4 2019 | $94,000 | -10.5% | 23,600 | 0.0% | 0.00% | – |
Q3 2019 | $105,000 | +15.4% | 23,600 | 0.0% | 0.00% | – |
Q2 2019 | $91,000 | – | 23,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |